Literature DB >> 10700933

Population screening and mass chemoprophylaxis in Kiribati.

E C Daulako1.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10700933

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


× No keyword cloud information.
  6 in total

Review 1.  The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.

Authors:  Anne Schoenmakers; Liesbeth Mieras; Teky Budiawan; Wim H van Brakel
Journal:  Res Rep Trop Med       Date:  2020-10-15

2.  CHEMOPROPHYLAXIS TO CONTROL LEPROSY AND THE PERSPECTIVE OF ITS IMPLEMENTATION IN BRAZIL: A PRIMER FOR NON-EPIDEMIOLOGISTS.

Authors:  Sergio Souza da Cunha; Ana Luiza Bierrenbach; Vitor Hugo Lima Barreto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-12       Impact factor: 1.846

Review 3.  Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.

Authors:  Malcolm S Duthie; Marivic F Balagon
Journal:  Risk Manag Healthc Policy       Date:  2016-04-27

4.  Predicting the impact of household contact and mass chemoprophylaxis on future new leprosy cases in South Tarawa, Kiribati: A modelling study.

Authors:  Charlotte Gilkison; Stephen Chambers; David J Blok; Jan Hendrik Richardus; Eretii Timeon; Erei Rimon; Patricia Priest
Journal:  PLoS Negl Trop Dis       Date:  2019-09-20

5.  Surveillance of Leprosy in Kiribati, 1935-2017.

Authors:  Stephen T Chambers; Nabura Ioteba; Eretii Timeon; Erei Rimon; Helen Murdoch; Jared Green; Emma Trowbridge; Jane Buckingham; Arturo Cunanan; Jonathan Williman; Patricia Priest
Journal:  Emerg Infect Dis       Date:  2020-05       Impact factor: 6.883

Review 6.  Integrated Management of Skin NTDs-Lessons Learned from Existing Practice and Field Research.

Authors:  Rie R Yotsu
Journal:  Trop Med Infect Dis       Date:  2018-11-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.